(FILES) In this file photo taken on October 17, 2018, a marijuana plant is pictured in Vancouver, Canada. - Canadian cannabis producer Aphria on Friday, December 28, 2018 rejected a proposed Can2.8 billion (2.1 billion US) takeover bid by US-based Xanthic Biopharma, calling it hostile and under-valued. Green Growth Brands, a division of Xanthic Biopharma, presented a conditional offer of Can11 per share on December 27, 2018 after markets closed. (Photo by Don MacKinnon / AFP)
THE Star Online last week reported the Deputy Health Minister of Malaysia’s response to Thailand approving marijuana for medical use and research (tinyurl.com/star-cannabis). Marijuana is also known as cannabis, or ganja in Malay.
According to Deputy Minister Dr Lee Boon Chye, pharmaceutical firms wishing to register the drug for such use must provide the required standard information on its quality, efficacy and safety.
Already a subscriber? Log in
The Star Festive Promo: Get 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
